Need Help? Call 1­-866-­796-­7386
« back to stock screener

  XXII stock: 22nd Century Group Inc

Current Rating
Strong Sell

Previous Rating

Strong Sell
Our Stock Ratings
double the S&P500!
Learn more.
Company Statistics
Price
$3.35
Market Cap
359.6M
Sector
Health Care
Div. Growth
-
P/E
-
P/B
10.07
P/S
20.14
Dividend %
-
P/CF
26.1
P/FCF
-
Op. Cash Flow
-11.5K
FCF
-0.1
Op. Margin
-88.30%
Net Margin
-86.00%
ROE
-48.60%
ROI
-46.30%
ROA
-42.30%
EPS Growth
17.00%
Current Ratio
5.3
Debt/Equity
-
Company Price P/E Div. Yield Market Cap ($Mil) Rating
Endo International PLC (ENDP) $8.01 - - 1.75B Strong Buy
Brainstorm Cell Therapeutics I (BCLI) $3.46 - - 57.1M Strong Buy
Champions Oncology Inc (CSBR) $4.14 - - 43.7M Strong Buy
Veru Inc (VERU) $1.41 - - 63.3M Strong Buy
NovaBay Pharmaceuticals, Inc. (NBY) $3.55 - - 55M Strong Buy
Find great stocks now!
Avoid risky stocks
Enter your favorite tickers and click “Get Ratings”

Disclaimer

Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.

All analysis relies on publicly available financial information. Learn More